562 related articles for article (PubMed ID: 21248787)
1. The role of G protein-coupled receptors in the pathology of Alzheimer's disease.
Thathiah A; De Strooper B
Nat Rev Neurosci; 2011 Feb; 12(2):73-87. PubMed ID: 21248787
[TBL] [Abstract][Full Text] [Related]
2. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
3. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
4. The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease.
Tan JZA; Gleeson PA
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):697-712. PubMed ID: 30639513
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of the alpha-secretase pathway to treat Alzheimer's disease.
Zhang C; Saunders AJ
Discov Med; 2007 Aug; 7(39):113-7. PubMed ID: 18093473
[TBL] [Abstract][Full Text] [Related]
6. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
Zhang T; Chen D; Lee TH
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892243
[TBL] [Abstract][Full Text] [Related]
8. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.
Yuksel M; Tacal O
Eur J Pharmacol; 2019 Aug; 856():172415. PubMed ID: 31132354
[TBL] [Abstract][Full Text] [Related]
9. In search of pathogenic amyloid β-peptide in familial Alzheimer's disease.
Wolfe MS
Prog Mol Biol Transl Sci; 2019; 168():71-78. PubMed ID: 31699328
[TBL] [Abstract][Full Text] [Related]
10. The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.
Shah H; Patel A; Parikh V; Nagani A; Bhimani B; Shah U; Bambharoliya T
CNS Neurol Disord Drug Targets; 2020; 19(3):184-194. PubMed ID: 32452328
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein processing and bioenergetics.
Wilkins HM; Swerdlow RH
Brain Res Bull; 2017 Jul; 133():71-79. PubMed ID: 27545490
[TBL] [Abstract][Full Text] [Related]
12. The FAM3 superfamily member ILEI ameliorates Alzheimer's disease-like pathology by destabilizing the penultimate amyloid-β precursor.
Hasegawa H; Liu L; Tooyama I; Murayama S; Nishimura M
Nat Commun; 2014 Jun; 5():3917. PubMed ID: 24894631
[TBL] [Abstract][Full Text] [Related]
13. An overview of APP processing enzymes and products.
Chow VW; Mattson MP; Wong PC; Gleichmann M
Neuromolecular Med; 2010 Mar; 12(1):1-12. PubMed ID: 20232515
[TBL] [Abstract][Full Text] [Related]
14. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
15. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
[TBL] [Abstract][Full Text] [Related]
16. Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer's Aβ oligomers.
Gandy S
Trends Mol Med; 2023 Jul; 29(7):487-488. PubMed ID: 37169660
[TBL] [Abstract][Full Text] [Related]
17. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review.
Ahmad SS; Khan S; Kamal MA; Wasi U
CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein.
Kanarek AM; Wagner A; Küppers J; Gütschow M; Postina R; Kojro E
FEBS J; 2017 Mar; 284(5):742-753. PubMed ID: 28102934
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
Liu L; Lauro BM; Wolfe MS; Selkoe DJ
J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
